The Effect of Intrathecal Epigallocatechin Gallate on the Development of Antinociceptive Tolerance to Morphine.
10.3344/kjp.2009.22.3.199
- Author:
Woong Mo KIM
1
;
Hong Beom BAE
;
Jeong Il CHOI
Author Information
1. Department of Anesthesiology and Pain Medicine, College of Medicine, Chonnam National University, Gwangju, Korea. aneszzz@naver.com
- Publication Type:Original Article
- Keywords:
antinociception;
epigallocatechin-3-gallate;
green tea;
morphine;
tolerance
- MeSH:
Cardiovascular System;
Catechin;
Catheters;
Humans;
Male;
Morphine;
Motor Neuron Disease;
Nervous System;
Neuralgia;
Neurodegenerative Diseases;
Neuroprotective Agents;
Nociception;
Rats, Sprague-Dawley;
Tea
- From:The Korean Journal of Pain
2009;22(3):199-205
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: A major ingredient of green tea is epigallocatechin-3-gallate (EGCG), and this is known to have many beneficial effects for cancer prevention and also on the cardiovascular system and neurodegenerative diseases through its anti-oxidant, anti-angiogenic, anti-inflammatory, lipid-lowering and neuroprotective properties. Its actions on nociception and the spinal nervous system have been examined in only a few studies, and in these studies EGCG showed an antinociceptive effect on inflammatory and neuropathic pain, and a neuroprotective effect in motor neuron disease. This study was performed to investigate the effect of EGCG on acute thermal pain and the development of morphine tolerance at the spinal level. METHODS: The experimental subjects were male Sprague-Dawley rats and the Hot-Box test was employed. A single or double-lumen intrathecal catheter was implanted at the lumbar enlargement for drug administration. An osmotic pump was used to infuse morphine for 7 days for induction of morphine tolerance. EGCG was injected repeatedly for 7 days at twice a day through the intrathecal catheter. RESULTS: Intrathecal EGCG increased the paw withdrawal latency (PWL) after repeated administration for 7 days at twice a day, but this did not happen with administering on single bolus injection of EGCG. In addition, the antinociceptive effect of intrathecal morphine was not affected by co-administration with EGCG. A continuous 7-day infusion of morphine caused a significant decrease of the PWL in the control group (M + S, morphine plus saline). In contrast, intrathecal EGCG injection over 7 days blocked the decrease of the PWL in the experiment group (M + E, morphine plus EGCG). CONCLUSIONS: Intrathecal ECGC produced a weak antinociceptive effect for acute thermal pain, but it did not change the morphine's analgesic effect. However, the development of antinociceptive tolerance to morphine was attenuated by administering intrathecal EGCG.
